Maridebart cafraglutide showed up to 19.9% weight loss in obesity and 17% in obesity-diabetes patients in a phase 2 trial. The drug's 21-day half-life, combining GLP-1 receptor agonism and GIP ...
Neurocrine Biosciences ($NBIX) announced an update on their ongoing clinical study. Neurocrine Biosciences (NBIX) has initiated a Phase 2 clinical ...
When is Stranger Things Season 5 going to premiere in India? Check the OTT platform, steps to watch, and more details here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback